Impact of fenestration patency on long-term Fontan outcomes

Eur J Cardiothorac Surg. 2026 Jan 20:ezag047. doi: 10.1093/ejcts/ezag047. Online ahead of print.ABSTRACTOBJECTIVES: Routine creation of a fenestration during Fontan completion is our policy to stabilize early circulation. This study evaluated its validity by examining the impact of fenestration pate

S Sakura Horie

Fibrin as a Versatile Fibrous Biopolymer

Subcell Biochem. 2026;113:413-473. doi: 10.1007/978-3-032-05273-5_13.ABSTRACTFibrin is a fibrous biopolymer that plays a crucial role in hemostasis, thrombosis, wound healing, and various other biological functions and pathological conditions. The X-ray crystallographic structure of fibrinogen, alon

J John W Weisel

2025 Egyptian guidelines for the management of dyslipidemia

Egypt Heart J. 2026 Jan 20;78(1):6. doi: 10.1186/s43044-026-00716-9.ABSTRACTBACKGROUND: The burden of premature atherosclerotic cardiovascular disease (ASCVD) in Egypt remains disproportionately high, and current international dyslipidemia guidelines have proven insufficient in achieving target lipi

A Ashraf Reda

Potential of imaging in the clinical routine : Focus on cardiovascular MRI

Herz. 2026 Jan 20. doi: 10.1007/s00059-025-05359-1. Online ahead of print.ABSTRACTCardiac magnetic resonance imaging (CMR) provides decisive advantages, particularly in coronary heart disease, myocarditis and cardiomyopathy. It accurately detects ischemia, scarring, edema and microvascular disorders

N Nadine Abanador-Kamper

Liposomes in tumor treatment: a double-edged sword

Sci China Life Sci. 2026 Jan 9. doi: 10.1007/s11427-025-3059-3. Online ahead of print.ABSTRACTWhile FDA-approved liposomal drugs (e.g., Doxil®) have demonstrated improved toxicity profiles and targeted delivery, emerging evidence reveals paradoxical pro-angiogenic and immunosuppressive effects that

G Guo Wu

Environmental Stressors and Cardiovascular Health: Acting Locally for Global Impact in a Changing World: A statement of the European Society of Cardiology, the American College of Cardiology, the American Heart Association, and the World Heart Federation

J Am Coll Cardiol. 2026 Jan 20:S0735-1097(26)00078-1. doi: 10.1016/j.jacc.2026.01.015. Online ahead of print.ABSTRACTNon-communicable diseases (NCDs) account for 70% of global mortality and are responsible for over 38 million deaths annually, with cardiovascular disease (CVD) constituting most of th

T Thomas Münzel

Berberine Reduces Atrial Lipotoxicity and Endoplasmic Reticulum Stress to Alleviate Heart Failure With Preserved Ejection Fraction (HFpEF)-Associated Atrial Fibrillation via AMPK Signaling

Phytother Res. 2026 Jan 20. doi: 10.1002/ptr.70193. Online ahead of print.ABSTRACTHeart failure with preserved ejection fraction (HFpEF) and atrial fibrillation (AF) frequently coexist due to shared risk factors, yet optimal therapeutic interventions remain elusive. Berberine (BBR), a widely used is

Z Zijun Cao